// App-Quantinova.ai

OC 54.3 : Validation of the IMPROVE Hospital-Acquired Venous Thrombosis Risk Assessment Model in The Medical Inpatients Thrombosis and Hemostasis Study (MITH) Population

Researchers

Presenter

  • A. Sparks

Principal Investigators

  • K. Wilkinson

  • A. Li

  • R. Thomas

  • N. Zakai

Medical Centers

  • University of Vermont, Burlington, Vermont, United States

  • Baylor College of Medicine, Houston, Texas, United States

  • Hennepin Health Care Research Institute, HHS, Minneapolis, MN, United States,

  • University of Vermont, COLCHESTER, Vermont, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • National Institutes of Health

Result

  • N/A